Tribe Asks Fed. Circ. To Pause Restasis Patent Reviews
Allergan and the Native American tribe that acquired patents for the drug company's Restasis medication urged the Federal Circuit on Friday to stop the Patent Trial and Appeal Board's review of...To view the full article, register now.
Already a subscriber? Click here to view full article